| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 04/25/2002 | CA2425310A1 Adjuvant composition comprising an immunostimulatory oligonucleotide and a tocol |
| 04/25/2002 | CA2423789A1 Bridged piperazine derivatives |
| 04/25/2002 | CA2423469A1 Methods and products related to pulmonary delivery of polysaccharides |
| 04/25/2002 | CA2423073A1 Recombinant antibody fragments as autoantibody antagonists |
| 04/24/2002 | EP1199372A2 Polymorphisms in the human P2X7 gene |
| 04/24/2002 | EP1199368A2 Use of adenoviral e4 reading frames to improve expression of a gene of interest |
| 04/24/2002 | EP1199362A2 Immunoregulator from the family designated 'leukocyte immunoglobulin-like receptors' (LIR) |
| 04/24/2002 | EP1199074A1 Pharmaceutical composition for preventing or treating a disease associated with an excess of il-12 production |
| 04/24/2002 | EP1199067A2 Prophylactic use of N-Methyl-D-Aspartate (NMDA) antagonists |
| 04/24/2002 | EP1198995A1 Anti-stress composition for incorporation in nutritional carriers |
| 04/24/2002 | EP1198581A1 Structural protein of adeno-associated virus with modified antigenicity, its production and its use |
| 04/24/2002 | EP1198568A1 Compositions and methods for the treatment of immune related diseases |
| 04/24/2002 | EP1198558A1 Method for obtaining dendritic cells, resulting dendritic cells and uses thereof for clinical purposes |
| 04/24/2002 | EP1198475A1 Highly purified cytokine activating factor and methods of use |
| 04/24/2002 | EP1198464A1 8-PHENYL-6,9-DIHYDRO- 1,2,4]TRIAZOLO 3,4- i i /i ]PURIN-5-ONE DERIVATIVES |
| 04/24/2002 | EP1198254A2 Carrier-drug conjugate |
| 04/24/2002 | EP1198250A1 Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens |
| 04/24/2002 | EP1198246A2 Methods for preventing or attenuating pathoangiogenic conditions by using the gbs-toxin (cm101) receptor as a vaccine |
| 04/24/2002 | EP1198241A1 Novel proteins |
| 04/24/2002 | EP1198233A1 Sulfonamide and sulfamide substituted imidazoquinolines |
| 04/24/2002 | EP1198232A1 Urea substituted imidazoquinolines |
| 04/24/2002 | EP0797452B1 Modulating the immune response |
| 04/24/2002 | CN1346406A Human ubiquitin ligase E3 for the modulation of NF-kappa 8 |
| 04/24/2002 | CN1346372A Anti-idiotypic antibodies against antibodies which inhibit the binding of immunoglobuline to its high affinity receptor |
| 04/24/2002 | CN1346370A Polypeptides involved in immune response |
| 04/24/2002 | CN1346364A 16-hydroxyestratrienes as selective estrogens |
| 04/24/2002 | CN1346363A The novel antisense-oligos with better stability and antisense effect |
| 04/24/2002 | CN1346361A Ether type lipid A1-carboxylic acid analogues |
| 04/24/2002 | CN1346350A Compound which inhibiti leukocyte adhesion mediated by VLA-4 |
| 04/24/2002 | CN1346348A Amide compounds and medicinal use thereof |
| 04/24/2002 | CN1346344A Substituted 2-aminobenzamide caspase ihibitors and the use thereof |
| 04/24/2002 | CN1346271A Quinazoline derivatives as angiogenesis inhibitors |
| 04/24/2002 | CN1083438C Substituted dismino-1,3,5-triazine derivatives |
| 04/24/2002 | CN1083264C Pharmaceutical compositions comprising an opiate ant agonist and calcium salts, their use for the treatment of endorphin-mediated pathlogies |
| 04/23/2002 | US6376669 Dye labeled imidazoquinoline compounds |
| 04/23/2002 | US6376665 Antiarthritic agents, antiinflammatory agents |
| 04/23/2002 | US6376658 Used as therapeutics for malaria |
| 04/23/2002 | US6376654 Myeloma cell and ovarian cancer cell surface glycoproteins, antibodies thereto, and uses thereof |
| 04/23/2002 | US6376540 Furan nitrone compounds |
| 04/23/2002 | US6376538 Antiinflammatory agents; autoimmune diseases |
| 04/23/2002 | US6376524 Triphenyl compounds as interleukin-4 antagonists |
| 04/23/2002 | US6376519 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines and inhibitors of cyclooxygenase-2 |
| 04/23/2002 | US6376517 For treating vision loss, preventing vision degeneration, and promoting vision regeneration (?neopsis?) |
| 04/23/2002 | US6376493 Selective inhibition of phosphodiesterase iv and tumor necrosis factor; useful in treating osteoporosis, tumors, autoimmune diseases, rheumatic diseases, and asthma |
| 04/23/2002 | US6376489 Cyclic AMP-specific phosphodiesterase inhibitors |
| 04/23/2002 | US6376480 Vitamin D derivatives with substituents at C-25, process for their production, intermediate products and use for the production of pharmaceutical agents |
| 04/23/2002 | US6376475 Inhibiting biosynthesis of sialyl galactosides involved in immune responses; for treating graft rejection, autoimmune diseases, and allergies |
| 04/23/2002 | US6376459 Specific for gp39 on t cells was able to inhibit helper t-cell mediated b-cell activation by binding to a novel 39 kd protein receptor on helper t-cell membranes |
| 04/23/2002 | US6376214 DNA encoding a novel homolog of CSBP/p38 MAP kinase |
| 04/23/2002 | US6375984 Aqueous-based pharmaceutical composition |
| 04/23/2002 | US6375973 Olopatadine and emedastine and an ophthalmically acceptable polymeric quaternary ammonium compound as a preservative |
| 04/23/2002 | US6375953 Treatment of infectious diseases with HSP70-peptide complexes |
| 04/23/2002 | US6375951 Therapeutic suppression of specific immune response by administration of oligomeric forms of antigen of controlled chemistry |
| 04/23/2002 | US6375950 Methods for inducing T cell unresponsiveness to donor tissue or organ in a recipient with gp39 antagonists |
| 04/23/2002 | CA2246727C Novel substituted n-methyl-n-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases |
| 04/18/2002 | WO2002031511A2 Modulation of ligand binding/enzymatic activity of alpha beta proteins |
| 04/18/2002 | WO2002031115A2 Nucleic acid molecules and polypeptides for immune modulation |
| 04/18/2002 | WO2002031110A2 Hematopoietic stem cell gene therapy |
| 04/18/2002 | WO2002030985A2 Inhibition of complement c5 activation for the treatment and prevention of delayed xenograft or acute vascular rejection |
| 04/18/2002 | WO2002030980A2 Use of anti-human integrin alpha d antibodies to treat spinal cord injury |
| 04/18/2002 | WO2002030938A1 Benzhydryl derivatives |
| 04/18/2002 | WO2002030936A1 Pyrrole-condensed morphinoid derivatives |
| 04/18/2002 | WO2002030935A1 Morphinoid derivatives as delta-opioid agonists and antagonists |
| 04/18/2002 | WO2002030924A1 Quinazoline derivatives with anti-tumour activity |
| 04/18/2002 | WO2002030908A1 Inhibitors of protein kinases |
| 04/18/2002 | WO2002030907A1 Pyrazole derivatives for the treatment of viral diseases |
| 04/18/2002 | WO2002030898A1 N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as ccr33 receptor antagonists |
| 04/18/2002 | WO2002030888A2 Tricyclic compounds and uses thereof |
| 04/18/2002 | WO2002030876A2 Cyclic carboxylic acids as integrin antagonists |
| 04/18/2002 | WO2002030875A1 Beta-amino acid derivatives as integrin receptor antagonists |
| 04/18/2002 | WO2002030874A2 Aliphatic, cyclic amino carboxylic acids as integrin antagonists |
| 04/18/2002 | WO2002030468A1 Complexes for transferring nucleic acids into cells |
| 04/18/2002 | WO2002030458A1 Yersinia adhesion protein as vaccine adjuvant |
| 04/18/2002 | WO2002030435A1 Treatment of t cell disorders |
| 04/18/2002 | WO2002030433A2 Use of stem cells and cd6-depleted stem cells for inducing tolerance of allogenic transplants and/or for treating leukaemia |
| 04/18/2002 | WO2002030426A1 Aza- and polyaza-naphthalenyl-carboxamides useful as hiv integrase inhibitors |
| 04/18/2002 | WO2002030423A1 NF-λB INHIBITORS |
| 04/18/2002 | WO2002030353A2 NF-λB INHIBITORS |
| 04/18/2002 | WO2002030351A2 Improvement of graft acceptance through manipulation of thymic regeneration |
| 04/18/2002 | WO2002030320A2 Stimulation of thymus for vaccination development |
| 04/18/2002 | WO2002030259A2 Disease prevention by reactivation of the thymus |
| 04/18/2002 | WO2002030257A2 Normalization of defective t cell responsiveness through manipulation of thymic regeneration |
| 04/18/2002 | WO2002014499A9 Claudin polypeptides |
| 04/18/2002 | WO2002012210A9 Biphenyl derivatives and their use as ppar-gamma receptor activators |
| 04/18/2002 | WO2002011740A3 'slow release' pharmaceutical compositions comprising lithium carbonate |
| 04/18/2002 | WO2002009793A8 Device for treating immune diseases |
| 04/18/2002 | WO2002008272A3 High affinity soluble interleukin-18 receptor |
| 04/18/2002 | WO2002008217A3 COUMARIN DERIVATIVES USEFUL AS TNFα INHIBITORS |
| 04/18/2002 | WO2002007721A3 Use of cox-2 inhibitors for preventing immunodeficiency |
| 04/18/2002 | WO2002006478A3 Extracellular matrix protein |
| 04/18/2002 | WO2002002541A3 Inhibitors of copper-containing amine oxidases |
| 04/18/2002 | WO2001093902A3 Immunostimulatory rna/dna hybrid molecules |
| 04/18/2002 | WO2001085766A3 Novel eosinophil cationic proteins used in the treatment of asthmatic and allergic disorders |
| 04/18/2002 | WO2001082958A3 Methods of producing membrane vesicles |
| 04/18/2002 | WO2001082952A3 USE OF α-MSH AND EPO FOR PREVENTING OR TREATING ISCHEMIC CONDITIONS |
| 04/18/2002 | WO2001081574A3 Regulation of nf-at interacting protein nip 45 variant |
| 04/18/2002 | WO2001080807A3 Medicine containing polysaccharide substances for activating apoptosis |
| 04/18/2002 | WO2001072777A3 Human transcription factors |
| 04/18/2002 | WO2001070247A3 Salmonella vaccine materials and methods |
| 04/18/2002 | WO2001068570A3 Il-8 receptor antagonists |